Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Advancing human genetics research and drug discovery through exome sequencing of the UK Biobank
Authors
Keywords
-
Journal
NATURE GENETICS
Volume 53, Issue 7, Pages 942-948
Publisher
Springer Science and Business Media LLC
Online
2021-06-29
DOI
10.1038/s41588-021-00885-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identification of a missense variant in SPDL1 associated with idiopathic pulmonary fibrosis
- (2021) Ryan S. Dhindsa et al. Communications Biology
- Evaluating drug targets through human loss-of-function genetic variation
- (2020) Eric Vallabh Minikel et al. NATURE
- The mutational constraint spectrum quantified from variation in 141,456 humans
- (2020) Konrad J. Karczewski et al. NATURE
- Exome sequencing and characterization of 49,960 individuals in the UK Biobank
- (2020) Cristopher V. Van Hout et al. NATURE
- Spontaneous Coronary Artery Dissection
- (2020) Keren J. Carss et al. Circulation-Genomic and Precision Medicine
- Massive NIH–industry project opens portals to target validation
- (2019) Elie Dolgin NATURE REVIEWS DRUG DISCOVERY
- Trends in clinical success rates and therapeutic focus
- (2019) Helen Dowden et al. NATURE REVIEWS DRUG DISCOVERY
- Phenotypes associated with genes encoding drug targets are predictive of clinical trial side effects
- (2019) Phuong A. Nguyen et al. Nature Communications
- Genomics of disease risk in globally diverse populations
- (2019) Deepti Gurdasani et al. NATURE REVIEWS GENETICS
- Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval
- (2019) Emily A. King et al. PLoS Genetics
- A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
- (2018) Noura S. Abul-Husn et al. NEW ENGLAND JOURNAL OF MEDICINE
- The UK Biobank resource with deep phenotyping and genomic data
- (2018) Clare Bycroft et al. NATURE
- Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
- (2018) Gregory G. Schwartz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
- (2017) Marc S. Sabatine et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrating evolutionary and regulatory information with a multispecies approach implicates genes and pathways in obsessive-compulsive disorder
- (2017) Hyun Ji Noh et al. Nature Communications
- Innovation in the pharmaceutical industry: New estimates of R&D costs
- (2016) Joseph A. DiMasi et al. JOURNAL OF HEALTH ECONOMICS
- A reference panel of 64,976 haplotypes for genotype imputation
- (2016) NATURE GENETICS
- VariantASGR1Associated with a Reduced Risk of Coronary Artery Disease
- (2016) Paul Nioi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Resolving TYK2 locus genotype-to-phenotype differences in autoimmunity
- (2016) C. A. Dendrou et al. Science Translational Medicine
- Effect of the DGAT1 inhibitor pradigastat on triglyceride and apoB48 levels in patients with familial chylomicronemia syndrome
- (2015) Charles Daniel Meyers et al. Lipids in Health and Disease
- A global reference for human genetic variation
- (2015) Richard A. Gibbs et al. NATURE
- The support of human genetic evidence for approved drug indications
- (2015) Matthew R Nelson et al. NATURE GENETICS
- TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex Traits
- (2015) Dorothée Diogo et al. PLoS One
- The International Serious Adverse Events Consortium
- (2014) Arthur L. Holden et al. NATURE REVIEWS DRUG DISCOVERY
- Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework
- (2014) David Cook et al. NATURE REVIEWS DRUG DISCOVERY
- Validating therapeutic targets through human genetics
- (2013) Robert M. Plenge et al. NATURE REVIEWS DRUG DISCOVERY
- Clinical Whole-Exome Sequencing for the Diagnosis of Mendelian Disorders
- (2013) Yaping Yang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Proof of mechanism for the DGAT1 inhibitor AZD7687: results from a first-time-in-human single-dose study
- (2012) H. Denison et al. DIABETES OBESITY & METABOLISM
- DGAT1 mutation is linked to a congenital diarrheal disorder
- (2012) Joel T. Haas et al. JOURNAL OF CLINICAL INVESTIGATION
- A framework for human microbiome research
- (2012) NATURE
- Genome-wide association studies for complex traits: consensus, uncertainty and challenges
- (2008) Mark I. McCarthy et al. NATURE REVIEWS GENETICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started